Integrated diagnosis and treatment for chronic kidney disease outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a cohort of 1000 patients with chronic kidney disease (CKD) to evaluate the effectiveness of integrated diagnosis and treatment approaches in a real-world setting. Participants will undergo regular monitoring and management of various health parameters, including blood pressure, blood glucose, and anemia, while receiving guidance on diet and exercise. The study will also analyze the clinical prognosis of patients based on different risk stratifications and identify factors associated with cardiovascular disease outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* ≥18 years old;
* Voluntarily signed informed consent;
* Patients who are estimated to develop CKD.

Exclusion Criteria:

* Age \< 18 or ≥100 years;
* Unable to comply with the procedures stipulated in this study;
* Estimated follow-up time ≤6 months.

Where it's running

• Nephrology Department of Beijing Jishuitan Hospital
  Beijing, Beijing Municipality, China Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Community-based exercise and lifestyle program for people at risk of metabolic syndrome

  A community program tests whether a structured exercise and lifestyle plan can improve heart and blood health in people with hypertension, high cholesterol, or high blood sugar.

  Recruiting Fu Jen Catholic University · New Taipei City · NCT07578090

• Exercise-prescription mini-program for people with high blood pressure, high blood sugar, high cholesterol, or high uric acid.

  This study will try a digital exercise-prescription mini-program to help adults with one or more of the 'Four Highs' increase physical activity and improve related health measures over six months in primary care.

  Recruiting China National Center for Cardiovascular Diseases · Beijing · NCT07400549

• DISC-0974-201 for adults with IBD-related anemia

  This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.

  Recruiting at 15 sites Phase 2 Disc Medicine, Inc · Birmingham, Alabama and 14 other locations · NCT07368972

• Streamlined renal denervation with Spyral for uncontrolled high blood pressure

  This trial will test whether a shorter, simpler renal denervation procedure using the Symplicity Spyral system can lower blood pressure in adults with uncontrolled hypertension.

  Recruiting at 20 sites Medtronic Vascular · Melbourne and 20 other locations · NCT07115953

• National registry for people with myelofibrosis and anemia in Germany.

  This project will collect health, treatment, and quality-of-life information from people in Germany with primary or secondary myelofibrosis and anemia to see how their care and symptoms change over time.

  Recruiting iOMEDICO AG · Multiple Locations · NCT06976918

• Gemini multi-organ denervation for uncontrolled high blood pressure

  The Gemini System is being tested to see if multi-organ denervation is safe and can lower blood pressure in adults with uncontrolled hypertension, with or without high cardiovascular risk.

  Recruiting at 18 sites Medtronic Vascular · Stanford, California and 17 other locations · NCT06907147

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.